Seems to me that ECOS (the public corporation) is just a bit player in this entire production?
From the 2016 10-K filed in August:
That $485,000 note to Hanscom K, (plus over $50,000 in accrued interest @ 16%), was due Nov. 1.
ECOS had not announced any sales revenue for 2017, outside the pilot machine sold to LRS (via ECOS/BIOart LLC) in Dec 2016? My guess is the $485,000 was the net cost from the Korean company that made the machine that LRS is paying $650,000 for? LRS and ECOS split the mark-up 50/50, so after installation expenses, ECOS may net around $50,000 from that first sale? That won't even cover the interest owed to Hanscom K? Hanscom K should get their note repaid if LRS pays for the machine this month. ECOS gets nothing?